Accuracy of pre-interventional computed tomography angiography post-processing software and extravascularly calibrated devices to determine vessel diameters: comparison with an intravascularly located calibrated catheter

Abstract

Background

Accurate vessel sizing might affect treatment outcome of endovascular therapy.

Purpose

To compare accuracy of peripheral vessel diameter measurements using pre-interventional computed tomography angiography post processing software (CTA-PPS) and extravascularly located calibrated devices used during digital subtraction angiography (DSA) with an intravascular scaled catheter (SC).

Material and Methods

In 33 patients (28 men, mean age = 72 ± 11 years) a SC was used during DSA of the femoro-popliteal territory. Simultaneously, one scaled radiopaque tape (SRT) was affixed to the lateral thigh, one scaled radiopaque ruler (SRR) was positioned on the angiography table. For each patient, diameters of five anatomic landmarks were measured on DSA images after calibration using different scaled devices and CTA-PPS. Diameters were compared to SC (reference) and between groups of non-obese (NOB) and obese (OB) patients.

Results

In total, 660 measurements were performed. Compared to the reference, SRT overestimated the diameter by 1.2% (range = -10–12, standard deviation [SD] = 4.1%, intraclass correlation coefficient [ICC] = 0.992, 95% confidence interval [CI] = 0.989–0.992, P = 0.01), the SRR and CTA-PPS underestimated it by 21.3% (range = 1–47, SD = 9.4%, ICC = 0.864, 95% CI = 0.11–0.963, P = 0.08) and 3.2% (range = 17–38, SD = 9.7%, ICC = 0.976, 95% CI = 0.964–0.983, P = 0.01), respectively. Underestimation using the SRR was greatest in the proximal superficial-femoral artery (31%) and lowest at the P2 level of the popliteal artery (15%). In the NOB group, diameter overestimation of the SRT was 0.8% (range = 4–7, SD = 4.2%, B = 0.071, 95% CI = 0.293–0.435, P = 0.08) compared to the OB group of 1.6% (range = −7–4, SD = 2.9%, B = 0.010, 95% CI = 0.474–0.454, P = 0.96). Diameter underestimation of the SRR was 17.3% (range = 13–21, SD = 3.1%, B = 0.946, 95% CI = 0.486–1.405, P = 0.002) in the NOB group, 23.3% (range = 11–36, SD = 6.6%, B = 0.870, 95% CI = 0.268–1.472, P = 0.007) in the OB group.

Conclusion

For calibrated measurements SRT and CTA-PPS prove accurate compared to the reference, while SRR does not. Obesity has a significant impact on underestimation of diameter if SRR is used.

Keywords

Digital subtraction angiography peripheral artery disease calibration computed tomographic angiography software

Get full access to this article

View all access options for this article.

References

Norgren

Hiatt

Dormandy

et al.

Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45: 5–67.

Health Quality Ontario. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment. Ont Health Technol Assess Ser 2015; 20: 1–62.

Tepe

Laird

Schneider

et al.

Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015; 5: 495–502.

Saxon

Chervu

Jones

et al.

Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol 2013; 2: 165–173.

Saxon

Dake

Volgelzang

et al.

Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 6: 823–832.

Garcia

Jaff

Metzger

et al.

Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circ Cardiovasc Interv 2015; 5: e000937–e000937.

Zhao

Nikanorov

Virmani

et al.

Late stent expansion and neointimal proliferation of oversized Nitinol stents in peripheral arteries. Cardiovasc Intervent Radiol 2009; 4: 720–726.

Laird

Katzen

Scheinert

et al.

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267–276.

Schillinger

Sabeti

Loewe

et al.

Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 18: 1879–1888.

10.

Clark

Groffsky

Soulen

. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001; 8: 923–33.

11.

Capek

McLean

Berkowitz

. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991; 2: 170–180.

12.

Salman

Vazquez-Padron

Castro

et al.

Measurement of vessel diameter during angioplasty: are we accurately performing this task?

Semin Dial 2014; 4: 38–41.

13.

Snow

Bennetts

. Technical report: A low cost technique for vessel sizing in angioplasty. Clin Radiol 1998; 12: 929–931.

14.

Fitzgerald

Oshima

Hayase

et al.

Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000; 5: 523–530.

15.

Oemrawsingh

Mintz

Schalij

et al.

Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003; 1: 62–67.

16.

Stone

Hodgson

St Goar

et al.

Improved procedural results of coronary angioplasty with intravascular ultrasound-guided balloon sizing: the CLOUT Pilot Trial. Clinical Outcomes With Ultrasound Trial (CLOUT) Investigators. Circulation 1997; 8: 2044–2052.

17.

Iida

Takahara

Soga

et al.

Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther 2014; 4: 485–492.

18.

Ascher

Marks

Hingorani

. Duplex-guided infrainguinal balloon angioplasty and stenting. A 4-year experience. J Cardiovasc Surg (Torino) 2008; 2: 151–158.